[Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma] [0.03%]
首次硼替佐米耐受性转换卡非佐米治疗多发性骨髓瘤的临床研究
Ying Yao,Xiao-Lan Shi,Pan-Feng Wang et al.
Ying Yao et al.
Objective: To evaluate the feasibility of in-class transition（iCT） first-line bortezomib intolerance to carfilzomib in the treatment of patients with multiple myeloma（MM）. ...
[Study on the Mechanism of MALAT1 Promoting Angiogenesis in Myeloma-Derived Exosomes] [0.03%]
长非编码RNA MALAT1促进多发性骨髓瘤外泌体促血管生成的作用机制研究
Mu-Yun Wu,Jie Zhang,Na-Yan Yi et al.
Mu-Yun Wu et al.
Objective: To investigate the regulatory effect and molecular mechanism of lncRNA MALAT1 mediated by myeloma-derived exosomes on angiogenesis through in vitro and in vivo experiments. ...
[The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma] [0.03%]
血浆cfTFEB和miR-1246预测多发性骨髓瘤患者硼替佐米疗效的临床价值分析
Rong-Juan Zhang,Wei Wang,Ying Meng et al.
Rong-Juan Zhang et al.
Objective: To investigate the clinical value of plasma cfTFEB and miR-1246 in predicting the efficacy of bortezomib therapy in patients with multiple myeloma (MM). ...
[Analysis of Immunophenotype and Clinical Biological Characteristics of Mature T-Cell Lymphoma and Clonal T Cells of Undetermined Significance] [0.03%]
成熟T细胞淋巴瘤及意义未明的克隆性T细胞免疫表型分析及临床特征研究
Zhao-Bo Li,Wei Cheng,Zhou-Feng Huang et al.
Zhao-Bo Li et al.
Objective: To analyze the immunophenotype and clinical characteristics of mature T-cell lymphoma (TCL) and clonal T cells of undetermined significance (T-CUS), and to explore the application value of flow cytometry in the...
[Expression of CD7 in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance] [0.03%]
CD7在结外自然杀伤细胞/NKT细胞淋巴瘤患者表达及其临床意义
Yu-Jie Zhao,Qi-Qi Linghu,Jun-Peng Huang et al.
Yu-Jie Zhao et al.
Objective: To analyze the expression of CD7 in patients with extranodal NK/T-cell lymphoma (ENKTL) and its clinical significance. Methods: ...
[Comparison of Different Staging Systems of Extranodal NK/T Cell Lymphoma and Prognosis Analysis] [0.03%]
不同病理分期系统在外周T细胞淋巴瘤中的比较及预后分析
Feng-Qin Shi,Ming Zhao,Yuan Jia et al.
Feng-Qin Shi et al.
Objective: To compare the value of Ann Arbor stage and CA stage in predicting the survival of extranodal NK/T cell lymphoma (ENKTL), and to explore its clinical features and prognosis. ...
[Clinical Characteristics and Prognostic Analysis of Patients with EBV-Positive Diffuse Large B-Cell Lymphoma] [0.03%]
[EBV阳性弥漫大B细胞淋巴瘤的临床特征和预后分析]
Feng-Ya Nan,Qi-Tang Huang,Na-Na Wang et al.
Feng-Ya Nan et al.
Objective: To explore the clinical features and prognosis of patients with Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL). Method...
[Prognostic Value of Prognostic Nutritional Index and Lymphocyte-to-Monocyte Ratio in Patients with Follicular Lymphoma] [0.03%]
预营养指数和淋巴细胞与单核细胞比值对滤泡性淋巴瘤患者的预后价值分析
Qi-Miao Shan,Dan Luo,Hua Ding et al.
Qi-Miao Shan et al.
Objective: To investigate the prognostic value of prognostic nutritional index (PNI) and lymphocyte-to-monocyte ratio (LMR) in patients with follicular lymphoma (FL). ...
[Clinical Analysis of Autologous Hematopoietic Stem Cell Transplantation in Treatment of Mantle Cell Lymphoma: a Multicenter Retrospective Study] [0.03%]
自体造血干细胞移植治疗套细胞淋巴瘤的临床分析（多中心回顾性研究）
Long Pang,Ping Yang,Hong-Mei Jing
Long Pang
Objective: To investigate the efficacy and prognostic factors of autologous hematopoietic stem cell transplantation (ASCT) in the treatment of mantle cell lymphoma (MCL) in the real world. ...
[LncRNA PVT1 Regulates the MiR-20a-5p/HMGA2 Signaling Axis to Affect Proliferation and Apoptosis of Diffuse Large B-Cell Lymphoma Cells] [0.03%]
长链非编码RNA PVT1通过调节MiR-20a-5p/HMGA2信号轴影响弥漫大B细胞淋巴瘤增殖及凋亡的功能研究
Xiao-Wei Xu,Wutikuer Adina,Hong-Li Zhang et al.
Xiao-Wei Xu et al.
Objective: To investigate the effect of long non-coding RNA (lncRNA) PVT1 on proliferation and apoptosis of diffuse large B-cell lymphoma (DLBCL) cells and the underlying mechanisms. ...